Not exact matches
We created a mouse
xenograft model in which SiHa cervical cancer cells were injected into mice
subcutaneously, and the resultant tumors were treated with PAL three times a week for 6 weeks.
The in vivo anti-tumor activity of dual treatment on T - cell lymphoma was further evaluated in a murine
xenograft model in which KMT2D V5486M mutated Jurkat cells
subcutaneously injected into nude mice.
MCF7, 231, and 468 lines and an ER - α — positive metastatic sample (COB) were implanted
subcutaneously into mice, and
xenografts were harvested at different time points; half was embedded in paraffin for immunohistochemical analysis, whereas half was dissociated for mammosphere culture.